Intravenous Anesthetic Protects Hepatocyte from Reactive Oxygen Species-Induced Cellular Apoptosis during Liver Transplantation In Vivo

• Published in: Oxidative medicine and cellular longevity Vol. 2018; no. 2018; pp. 1 - 10
• Main Authors: Huang, Pinjie, Hei, Ziqing, Luo, Gangjian, Wu, Shan, Chen, Chaojin, Ge, Mian, Guan, Jianqiang, Zhang, Yihan, Han, Xue, Yao, Weifeng, Chen, Jiaxin
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01.01.2018; Hindawi; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Anesthesia; Anesthetics, Intravenous - administration & dosage; Animals; Apoptosis; Binding sites; Central nervous system agents; Cytokines; Hepatocytes - drug effects; Hepatocytes - metabolism; Hepatocytes - pathology; Inflammation; Ischemia; Kinases; Liver; Liver Transplantation - methods; Liver transplants; Male; Neurosciences; Neutrophils; Oxidases; Oxidative Stress; Physiology; Propofol; Propofol - administration & dosage; Protective Agents - administration & dosage; Proteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species - metabolism; Reperfusion Injury - metabolism; Reperfusion Injury - pathology; Reperfusion Injury - prevention & control; Rodents; Signal transduction; Transplantation; China; United States > US
• ISSN: 1942-0900; 1942-0994
• DOI: 10.1155/2018/4780615

Background. Liver transplantation leads to liver ischemia/reperfusion (I/R) injury, resulting in early graft dysfunction and failure. Exacerbations of oxidative stress and inflammatory response are key processes in the development of liver I/R injury. Intravenous anesthetic propofol potent effects on free radical scavenging and protects livers against I/R injury. However, the role and mechanism of propofol-mediated hepatic protection in liver transplantation is poorly understood. The aim of this study was to evaluate the role of propofol postconditioning in the liver I/R injury after liver transplantation. Methods. Forty-eight rats were randomly divided into six groups: rats receiving either sham operation or orthotopic autologous liver transplantation (OALT) in the absence or presence of propofol (high dose and low dose) postconditioning or intralipid control or VAS2870 (Nox2 special inhibitor). Eight hours after OALT or sham operation, parameters of organ injury, oxidative stress, inflammation, and NADPH-associated proteins were assessed. Results. After OALT, severe liver pathological injury was observed that was associated with increases of serum AST and ALT, which were attenuated by propofol postconditioning. In addition, especially high dose of propofol postconditioning reduced TNF-α, IL-1β, IL-6, TLR4, and NF-κB inflammatory pathway, accompanied with decrease of neutrophil elastase activity, MPO activity, 8-isoprotane, p47phox and gp91phox protein expressions, and increase of SOD activity. Inhibition of Nox2 by VAS2870 conferred similar protective effects in liver transplantation. Conclusion. Liver transplantation leads to severe inflammation and oxidative stress with NADPH oxidase activation. Propofol postconditioning reduces liver I/R injury after liver transplantation partly via inhibiting NADPH oxidase Nox2 and the subsequent inflammation and oxidative stress.